TNF and neoplasm: Because efficacy and safety of TNFα systemic therapy will depend on its selective delivery to the tumor microenvironment, initial in vivo experiments were performed to investigate RGD4C.TPA‐mediated TNFα gene delivery upon intravenous administration to tumor‐bearing mice.